APP and Alzheimer disease: In addition to the plaques and aggregates observed in the brain of AD patients, mutations in Amyloid Precursor Protein (APP) that lead to altered levels of Aβ are associated with familial AD, while Aβ expression also induces AD-like symptoms in cell and animal models [2–5].